Cite
MLA Citation
Stefano Barco et al.. “Enoxaparin for primary thromboprophylaxis in symptomatic outpatients with COVID-19 (OVID): a randomised, open-label, parallel-group, multicentre, phase 3 trial.” Lancet, vol. 9, no. 8, 2022, pp. e585–e593. http://access.bl.uk/ark:/81055/vdc_100159753353.0x00000a